Avsnitt
-
Liz Parrish shares her groundbreaking journey into gene therapy, her motivations driven by her son's diagnosis, and her vision for a future where aging and disease are conquerable. This conversation explores the science, ethics, and future of longevity research, emphasizing the importance of innovation and human rights in healthcare.
Chapters
00:00 Introduction and Liz Parrish's Background
02:49 Liz Parrish's First Human Gene Therapy Experience
03:39 Parenting a Child with Type 1 Diabetes
05:23 Children's Hospitals and Medical Challenges
07:10 The Cost and Accessibility of Life-Saving Treatments
08:08 Hope and Grief in Medical Innovation
10:10 Realization of Unconventional Approaches
11:54 Treating Biological Aging and Childhood Diseases
13:35 Criticism of Incremental Medical Progress
15:27 Resistance to Technological Change in Medicine
16:57 The Potential of Gene Therapy for Humanity
18:59 Biohacking and Scientific Rigor
21:02 The Future of Humanity Without Aging
23:12 The Day of Her Gene Therapy Treatment
25:48 Experiences During the Treatment Process
27:23 What Was Entering Her Body
29:45 Different Gene Therapies Used
30:40 Addressing Critics and Scientific Rigor
33:41 Overcoming Media and Regulatory Challenges
37:26 Debunking Cancer and Safety Myths
47:25 The Science of Telomerase and Cancer Risks
51:21 Gene Therapy Delivery Methods and Toxicity
52:34 Animal Data vs Human Data in Longevity Research
55:11 The Biggest Lie in Longevity Industry
56:32 Misunderstandings About Telomerase Activation
58:35 Regulatory Barriers and Economics in Aging Treatments
01:01:38 Mainstream Pharma's Skepticism Toward Aging as an Indication
01:06:28 The Urgency of Access to Longevity Treatments
01:10:07 Emotional Impact of Treatment Outcomes
01:14:36 The Future of Humanity and Aging
01:16:14 What Will Kill Us in a World Without Aging
01:20:55 Simulation Theory and Reality
01:23:00 Philosophy, Spirituality, and the Nature of Existence
01:25:02 The Power of Upgrading Our Mindset
01:27:18 Closing Remarks and Future Outlook
Get vidIQ to grow your channel faster! 🚀
https://vidiq.com/DrugDiaries
-
In this episode, Dr Elliot Justin discusses the fascinating connection between sexual health, cardiovascular health, and why the body often provides early warning signs long before more serious health issues emerge.
If you'd like to learn more about FirmTech and the technology discussed in this conversation, you can explore it using the link below.
As a listener of Drug Diaries, you'll receive 20% off your purchase using the code DRUGDIARIES.
🔗 Affiliate Link: https://myfirmtech.com/kaushiktrivediq5
A note on transparency: FirmTech sponsored this episode and Drug Diaries may earn a commission if you choose to make a purchase through this link. This comes at no additional cost to you.
Importantly, 100% of any commissions earned from this partnership will be donated to Childhood Cancer International (CCI), a global charitable organisation that supports children with cancer and their families in low- and middle-income countries.
Thank you for supporting both the podcast and this important cause.
Chapters
00:00 Breaking the Silence on Sexual Health
02:26 Understanding the Signals of Erectile Dysfunction
04:42 The Importance of Nocturnal Erections
07:32 The Role of Wearables in Sexual Health
09:51The Psychological Barriers to Discussing Sexual Health
12:33 The Misdiagnosis of Erectile Dysfunction
14:56 The Impact of Aging on Sexual Health
17:16 The Shift in Patient Attitudes
19:39 The Legacy of Sexual Health Advocacy
21:42 The Need for Action in Sexual Health
24:14 Planning for Pleasure in Relationships
32:08 Understanding Erectile Dysfunction: The Physiological and Psychological Factors
39:32 The Role of Technology in Sexual Health
44:25 Real User Stories: Transformative Experiences with the Ring
48:47 Behavior Change and the Importance of Tracking Sexual
HealthResources
Firm Tech Wearable Devices
Childhood Cancer International
Elliot Justin's Research on Sexual Health MonitoringGuest links
LinkedInTwitterGet vidIQ to grow your channel faster! 🚀
https://vidiq.com/DrugDiaries
-
Saknas det avsnitt?
-
At 57, hear how being proactive has allowed me to delay many of the typical signs of aging. This discussion highlights the importance of a healthy lifestyle and an aging mindset to experience aging well. Learn how small, consistent choices can contribute to healthy aging and provide longevity tips for everyone.
Explore the science of aging with Dr. Sandra Kaufmann, who breaks down aging into seven biological categories and discusses actionable strategies, supplements, and lifestyle choices to slow or reverse aging processes.
Chapters
00:00 Understanding Aging: A New Perspective
02:21 The Disconnect in Medicine: A Personal Journey
05:01 The Science of Aging: Chronological vs Physiological
07:51 Breaking Down Aging: The Kaufman Protocol
10:07 The Seven Tenets of Aging
12:55 The Role of Supplements in Longevity
15:42 Exploring the First Tenet: DNA and Telomeres
18:18 Mitochondrial Health: The Second Tenet
21:57 Pathways of Aging: The Third Tenet
25:47 The Foundations of Longevity: Diet and Exercise
27:46 Personalized Health Protocols: Tailoring to Individual Needs
31:05 Understanding Oxidative Stress and Its Impact
31:17 Glycation: The Hidden Dangers of Sugar
37:52 Debunking Longevity Myths: Hyperbaric Oxygen Therapy
39:49 Metformin: A Double-Edged Sword for Longevity
41:18 The Role of Supplements: Balancing Science and Basics
45:12 Key Overlooked Factors for Longevity
46:01 The Importance of Sleep
48:01 Supplements for Better Sleep
50:09 Democratizing Longevity
51:57 Future Perspectives on Aging
53:23 Defining a Well-Lived Life
54:30 Rapid Fire on Longevity Supplements
resources
The Kaufman Protocol - https://www.kaufmanprotocol.com
Sandra Kaufmann's Website - https://www.kaufmanprotocol.com
Metformin - https://en.wikipedia.org/wiki/Metformin
Resveratrol and Pterostilbene - https://en.wikipedia.org/wiki/Resveratrol
NMN and NR supplements - https://en.wikipedia.org/wiki/Nicotinamide_mono nucleotide
Exosome Therapy - https://www.exosome.com
Connect with
Kaushik Trivedi (Host) - https://www.instagram.com/drugdiaries_/
-
This video takes a thought-provoking journey into the fundamental question of why we age, exploring the intricate mechanisms of human biology. It delves into the concept of "biological age" and even presents a unique perspective on "cancer research" and its potential role in "evolution". The discussion also touches upon personal reflections on "mortality", prompting us to consider how to live longer.
Kaushik Trivedi interviews Dr. Bill Andrews, a pioneer in genetics and telomere research, about the science of aging, telomerase, and the obstacles to curing aging. They explore the biological mechanisms behind aging, the history of telomere research, and the societal challenges in achieving longevity breakthroughs. In this in-depth interview, Bill Andrews shares his pioneering work in telomere research, anti-aging therapies, and the future of human longevity. Discover how scientific breakthroughs, strategic funding, and personal discipline are shaping the quest to extend healthy lifespan beyond natural limits.
keywords
aging, telomeres, telomerase, genetics, longevity, biotech, science of aging, Dr. Bill Andrews, anti-aging research, biotech obstacles telomeres, anti-aging, longevity, scientific research, human lifespan, telomerase, aging therapies, biotech innovation, health optimization, future of medicine
Chapters
0:00:00 – 0:01:47 Trailer
0:01:47 – 0:03:27 Introduction
0:03:27 – 0:04:32 Why Bill is doing this interview
0:04:32 – 0:23:25 Bill’s background
0:23:25 – 0:28:40 Telomere Biology and Aging
0:28:40 – 0:30:20 Telomerase does not cause cancer
0:30:20 – 0:41:05 Evolution of Aging and other diseases
0:41:05 – 0:45:55 Causes of Aging
0:45:55 – 0:47:12 Why cure aging
0:47:12 – 0:54:53 More on Causes of Aging and Evolution
0:54:53 – 1:13:07 Obstacles to Curing Diseases and the Solutions.
1:13:07 – 1:28:30 How Bill Will Cure Aging
1:28:30 – 1:33:24 Bill’s Research at Sierra Sciences Up to Now.
1:33:24 – 1:36:06 More on Telomere Biology and Aging
1:36:06 – 1:41:38 Searching for Nutraceutical Telomerase Inducers
1:41:38 – 1:44:45 Touchstone Essentials and Telo-Vital
1:44:45 – 1:56:08 Telomere Length and Almost All Diseases
1:56:08 – 2:02:02 Should Aging NOT be Cured?
2:02:02 – 2:22:03 Bill’s Personal Longevity Practices
2:22:03 – 2:23:15 Bill’s Prediction of What Life Will be Like in 30 Years.
2:23:15 – 2:26:36 Longevity and Religion
Resources
The Immortalists (Documentary)
Kaushik Trivedi's Website
Dr. Bill Andrews' Research Lab
Sierra Sciences
Betty White
Caldwell Esselstyn's book 'The Prevent and Reverse Heart Disease'
Touchstone Essentials TeloVital
Kaufman Protocols by Dr. Sandra Kaufman
Aubrey de Grey's work on aging
Guest
links
Twitter
LinkedIn
Website
If you'd like to sponsor the show and elevate your brand with our audience, reach out to show host Kaushik Trivedi on LinkedIn and his team will reach out to fix up a chat to explore.
Connect with
Kaushik Trivedi (Host) - https://www.instagram.com/drugdiaries_/
-
Our latest segment introduces "Drug Diaries Den," a platform designed for innovators to present scientific ideas, aiming to accelerate **drug development**. Dr. Subhadra David showcases an innovative AI-enabled digital animal replacement technology, addressing the high failure rates in human clinical trials and improving **drug discovery**. This technology leverages **artificial intelligence** and human microphysiological platforms to enhance **clinical research** and advance **innovation in healthcare** by reducing reliance on traditional **animal research**.
This episode features a panel discussion on innovative approaches in drug development, focusing on AI-enabled human microphysiological systems as a replacement for animal testing. Experts share insights on scientific validation, translational feasibility, and the future of ethical, faster, and more accurate drug discovery.
Chapters
00:00 Introduction to Drug Diaries Den
02:01 Panel Introduction and Expertise
06:04 Presentation of Innovation by Dr. Subhadra Dhavit
16:54 Discussion and Panel Insights
17:20 The Potential of New Approaches in Drug Development
19:18 Challenges in Evaluating New Drug Modalities
20:20 Feedback and Insights on Drug Development Strategies
23:43 Regulatory Considerations and Validation in Drug Development
28:16 Exploring the Limits of New Technologies
31:30 Evaluating the Platform from a Venture Perspective
35:11 Commercial Opportunities and Challenges in Drug Development
39:55 Assessing Innovation in Biotechnology
44:29 Final Thoughts and Reflections on the Discussion
Eesources
Transcel Biologics
American Association for Precision Medicine
Genentech Roche
Rutgers University
Wise Capitals
If you'd like to sponsor the show and elevate your brand with our audience, reach out to show host Kaushik Trivedi on LinkedIn and his team will reach out to fix up a chat to explore.
Connect with
Kaushik Trivedi (Host) - https://www.instagram.com/drugdiaries_/
S. Dravida - https://www.linkedin.com/in/s-dravida-she-her-65011611/
Debraj Dasgupta - https://www.linkedin.com/in/debrajdasgupta/
Paul Agapow - https://www.linkedin.com/in/paul-agapow/
Sadanand Vadola - https://www.linkedin.com/in/sadanand-vodala-305b022a/
Dr. Prasun Mishra - https://www.linkedin.com/in/prasunjmishra/
-
Despite advancements in healthcare technology, the patient care experience often feels fragmented. This video highlights the disconnect between sophisticated medical innovations, like artificial intelligence for early disease detection, and the actual human connection patients receive. We explore how even with cutting-edge technology, the healthcare industry struggles to provide a truly integrated and empathetic experience for individuals.
Dr. Fatih Mehmet GUL shares insights on the evolution of healthcare, digital transformation, connected care, AI, and future trends. Discover how technology, human touch, and system re-engineering can create healthier communities and improve patient outcomes.
Chapters
00:00 The State of Healthcare Innovation
02:49 Defining Moments in Healthcare Leadership
05:44 Integrating Technology with Human Empathy
08:23 The Importance of Connected Care
11:21 Transforming Patient Experience
14:10 The Role of Caregivers in Healthcare
16:59 Re-engineering Healthcare Systems
20:11 The Next Generation of Patients
23:07 The Need for Continuous Patient Engagement
25:54 The Crisis of Healthcare Professionals
28:52 The Coexistence of Technology and Humanity
31:45 Rethinking Healthcare Operations
34:35 The True State of Global Healthcare
39:40 Navigating Healthcare Complexity
43:46 The Role of AI in Healthcare
48:38 AI Successes and Failures
53:25 Patient Experience and Technology
57:45 Challenges in Healthcare Innovation
01:01:58 Global Influences on Healthcare
01:03:13 Future of Healthcare: A Decade Ahead
01:07:55 Longevity and Healthy Aging
01:12:02 Myths vs. Realities in Healthcare
01:14:11 Confronting Healthcare Realities
Resources
Connected Care
Framework AI Governance in Healthcare
If you'd like to sponsor the show and elevate your brand with our audience, reach out to show host Kaushik Trivedi on LinkedIn and his team will reach out to fix up a chat to explore.
Connect with Kaushik Trivedi:
Instagram: https://www.instagram.com/drugdiaries_/
-
Is obesity a failure of the individual, or a chronic disease shaped by biology, environment, psychology, and systems? This video explores the complexities of obesity treatment, questioning whether it's an individual's fault or a deeper issue. We discuss how lifestyle medicine and understanding insulin resistance are crucial in effective weight management, moving beyond simple solutions.
Kaushik Trivedi hosts Sarah Le Brocq to explore the complex realities of obesity, emphasizing lived experience, science, policy, and systemic change. This conversation challenges oversimplified narratives and advocates for compassionate, evidence-based approaches.
Obesity, lived experience, healthcare policy, stigma, treatment, systemic change, mental health, medical innovation, advocacy
Chapters
00:00 Rethinking Obesity: A New Narrative
01:52 The Human Experience Behind Obesity
11:17 The Complexity of Obesity: Beyond Willpower
17:45 Stigma and Its Impact on Healthcare
22:27 From Personal Journey to Advocacy
25:44 Integrating Lived Experience in Healthcare Advocacy
27:12 Authenticity in Storytelling
28:45 The Bigger Picture in Advocacy
30:25 The Importance of Patient Voices
32:08 Current Trends in Obesity Care
37:44 Access to Innovative Treatments
38:39 Defining Obesity: A Complex Issue
43:24 Challenges in NHS Prescriptions
45:51 The Role of Pharmaceutical Companies
49:07 Envisioning Future Obesity Care
51:28 Personal Reflections on Resilience
55:04 A Message to Those Living with Obesity
If you'd like to sponsor the show and elevate your brand with our audience, reach out to show host Kaushik Trivedi on LinkedIn and his team will reach out to fix up a chat to explore.
Connect with Kaushik Trivedi:
Instagram: https://www.instagram.com/drugdiaries_/
-
keywords healthspan, functionality, aging, wellness, resilience, health metrics, functional capacity, dual task training, empowerment, social health
takeaways Health span is determined by how we function, not just lab results. Functional blindness refers to being unaware of our physical capabilities. Our weakest link in health can determine our overall health span. Fitness does not equate to resilience; balance is crucial. Functional metrics can predict health span better than disease indicators. The five domains of function are strength, cardiovascular health, mobility, structure, and cognition. Simple tests can assess functional capacity at home. Dual task training enhances brain function and resilience. Awareness of functional capacity empowers individuals to take action. Social engagement can enhance the experience of improving health span.
summary In this conversation, Prof. Scott Fulton discusses the concept of healthspan, emphasizing the importance of functionality over traditional health metrics. He introduces the idea of functional blindness, where individuals are unaware of their physical capabilities, and explains how our weakest link can determine overall health. Fulton outlines the five domains of function—strength, cardiovascular health, mobility, structure, and cognition—and provides practical assessments for individuals to gauge their functional capacity. He highlights the significance of dual task training for brain health and the empowering nature of awareness in shaping one's aging experience. The discussion concludes with a focus on the social aspects of functionality and the importance of community in enhancing healthspan.
Chapters
00:00 Understanding Health Span vs. Disease
03:12 The Concept of Functional Blindness
06:19 The Weakest Link in Health Span
09:20 Function as a Predictor of Health Span
14:15 The Five Domains of Function
18:57 Understanding VO2 Max
20:10 Simple Tests for Functional Assessment
25:23 Empowering Daily Life Choices
26:41 The Blue Zones and Functional Living
28:28 Defining Functional Age
28:52 Understanding Functional Ability Across Ages
31:17 The Shift from Reactive to Preventive Medicine
34:30 The Importance of Dual Task Training
43:54 Discovering Functional Blind Spots
47:54 Empowerment Through Awareness and Agency
51:27 The Social Aspect of Function and Healthspan
If you'd like to sponsor the show and elevate your brand with our audience, reach out to show host Kaushik Trivedi on LinkedIn and his team will reach out to fix up a chat to explore.
Connect with Kaushik Trivedi:
Instagram: https://www.instagram.com/drugdiaries_/
-
Our latest discussion explores the universal desire for a healthy, long life, emphasizing that aging is a primary driver of disease. We consider various approaches to healthy ageing and the pursuit of a longer healthspan. While true solutions for how to live longer currently favor the wealthy, understanding aging biology and metabolic health are crucial for disease prevention. This episode prompts us to rethink access to longevity solutions for everyone.
In this conversation, Kaushik Trivedi and Dylan Livingston explore the implications of aging as a treatable condition rather than an inevitable decline. They discuss the role of policy in shaping longevity research, the need for societal acceptance of aging interventions, and the potential economic benefits of extending healthy lifespans. The conversation also touches on the risks associated with longevity breakthroughs and the importance of making these advancements accessible to all. Ultimately, they emphasize the need for a shift in healthcare from reactive to proactive measures, highlighting the societal changes that could arise from longer, healthier lives.
Chapters
00:00 The Uncomfortable Truth About Aging
01:26 The Disruption of Aging Policy
03:11 Dylan's Journey into Longevity Advocacy
08:44 Bridging Science and Policy
10:24 The Need for Diverse Voices in Longevity
12:12 Inspiration from Pioneers in the Field
13:04 The Unconventional Path to Advocacy
15:16 Curiosity Over Skepticism in Policy Discussions
19:18 Bipartisan Support for Longevity Initiatives
24:34 Aging 1.0 vs. Aging 2.0
27:07 The Economic Impact of Healthy Aging
30:11 Making Longevity Accessible to All
32:41 The Role of Government in Longevity Drug Accessibility
34:08 Awareness and Misconceptions in Longevity
36:51 Realism vs. Hype in Longevity Innovations
39:25 Mainstreaming Longevity Medicine
43:42 Government's Role in Longevity Interventions
47:35 Societal Changes with Extended Lifespan
53:09 The Future of Work and Leisure in an AI-Driven World
54:07 Potential Risks of Extended Lifespan
56:21 Hope and Challenges in Longevity Advocacy
If you'd like to sponsor the show and elevate your brand with our audience, reach out to show host Kaushik Trivedi on LinkedIn and his team will reach out to fix up a chat to explore.
Connect with Kaushik Trivedi:
Instagram: https://www.instagram.com/drugdiaries_/
-
In this conversation, Kaushik Trivedi and Debraj Dasgupta explore the evolving landscape of careers, leadership, and the importance of human connection in a rapidly changing world. They discuss the challenges of digital transformation, the need for a cultural shift in organizations, and the significance of building communities. Debraj shares his personal journey from corporate life to entrepreneurship, emphasizing the importance of redefining success and fulfillment. The conversation highlights the necessity of human relationships in an age dominated by technology and AI, and the responsibility of leaders to invest in the next generation.
Takeaways Most careers stall rather than end, leading to a crisis of meaning. Digital transformation fails when organizational culture does not evolve. Networking should focus on building trust rather than just contacts. Success and fulfillment can diverge in one's career journey. Reinvention requires courage and a willingness to embrace uncertainty. Human connection becomes more valuable as technology advances. The future of work will involve collaboration between humans and AI. Companies must adapt to retain talent by fostering a supportive culture. Building communities is essential in the digital age. Leaders have a responsibility to mentor and support the next generation.
Chapters
00:00 The Crossroads of Career and Meaning
02:13 Navigating Career Phases and Personal Growth
04:55 Redefining Success and Fulfillment
07:35 The Courage to Reinvent
09:58 Building Digital Culture vs. Digital Projects
12:23 The Myths of Digital Transformation
14:53 Future-Ready Talent and Retention Challenges
19:43 Navigating the Future of Work
22:03 Identity and Career Transitions
24:19 The Art of Networking
26:53 Building Communities in a Digital Age
29:12 AI's Role in Leadership
31:30 The Leadership Vacuum and Next Generation
32:57 The Responsibility of Experienced Leaders
34:28 The Importance of Human Connection
If you'd like to sponsor the show and elevate your brand with our audience, reach out to show host Kaushik Trivedi on LinkedIn and his team will reach out to fix up a chat to explore.
Connect with Kaushik Trivedi:
Instagram: https://www.instagram.com/drugdiaries_/
-
In this enlightening conversation, Kaushik Trivedi speaks with Sophia Lugo, CEO of Radar Therapeutics, about the transformative potential of programmable genetic medicines. They explore the limitations of current mRNA therapies, the importance of precision over power in medicine, and the ethical implications of innovation in healthcare. Sophia shares her personal journey, the challenges of building a biotech company, and the need for public trust in genetic medicine. This discussion highlights the future of medicine as not just more advanced, but more intentional and responsible.
The biggest problem in modern medicine may be the bluntness of drugs. Medicines should not only act but also decide when and where to work. Sophia Lugo is driven by a desire for justice and equal access to technology. Personal responsibility and hard work are key to success. mRNA therapies have not yet achieved therapeutic approval, only vaccines. Precision in medicine is becoming more important than raw power. Programmable medicines could fundamentally change drug development. Public trust in genetic medicine involves emotional and ethical considerations. The human aspect of building a biotech company is often more challenging than the science. The future of medicine will be more intentional, focusing on the impact on humanity.
00:00 The Evolution of Medicine: From Power to Precision
11:11 The Limitations of Current Genetic Therapies
If you'd like to sponsor the show and elevate your brand with our audience, reach out to show host Kaushik Trivedi on LinkedIn and his team will reach out to fix up a chat to explore.
Connect with Kaushik Trivedi:
Instagram: https://www.instagram.com/drugdiaries_/
-
In this conversation, Kaushik Trivedi speaks with Dr. Reinhard Berkels,, a seasoned leader in medical affairs, about the critical role of medical affairs in the pharmaceutical industry. They discuss the navigation system that medical affairs provides for drug launches, the importance of real-world evidence, and the evolving role of MSLs. Dr. Berkels shares insights from his extensive experience, emphasizing the need for collaboration, empathy, and effective communication in medical affairs. The conversation also touches on the impact of digital transformation and the importance of understanding cultural differences in global medical affairs.
Chapters
00:00 Navigating the Complex World of Medical Affairs
02:00 The Journey into Medical Affairs
11:48 Understanding the Role of Medical Affairs
14:09 First Impressions in Medical Affairs
15:42 Myths and Misconceptions about Medical Affairs
17:21 Cultural Differences in Medical Affairs
19:18 The Role of MSLs in Clinical Trials
24:49 Redefining the MSL Role for Today
28:02 Challenges in Deploying MSLs Early
32:40 Post-Pandemic Changes in Engagement
36:25 The Omnichannel Approach in Medical Affairs
39:39 Digital Transformation in Medical Affairs
40:08 Harnessing AI in Medical Affairs
43:04 Transformative Power of AI in Research
48:03 The Role of Medical Affairs in Drug Launches
51:52 Collaboration and Communication in Medical Affairs
56:12 Real-World Evidence and Its Impact
01:00:01 Core Values and Leadership in Medical Affairs
If you'd like to sponsor the show and elevate your brand with our audience, reach out to show host Kaushik Trivedi on LinkedIn and his team will reach out to fix up a chat to explore.
Connect with Kaushik Trivedi:
Instagram: https://www.instagram.com/drugdiaries_/
Linkedin: https://www.linkedin.com/in/kaushiktrivedi/
-
In this conversation, Gavin shares his journey from a young boy in South Wales to a senior leader in the pharmaceutical industry. He reflects on the pivotal experiences that shaped his leadership style, emphasizing the importance of personal stories, transparency, and the balance between affordability and innovation in healthcare. Gavin discusses the evolving role of market access professionals and the impact of recent policy changes on the industry. He concludes with thoughts on legacy, the importance of creating a safe environment for open dialogue, and the need for leaders to be authentic and vulnerable.
Chapters
00:00 The Hidden Decisions in Healthcare
02:11 Gavin Lewis: A Journey Through Healthcare Leadership
04:47 Formative Experiences: From South Wales to Economics
07:21 Values and Beliefs in Leadership
09:58 Navigating Moral Stress in Healthcare Decisions
12:09 Leading Through Ambiguity and Uncertainty
14:51 Balancing Affordability, Sustainability, and Innovation
17:02 The Superpower of Access Professionals
19:25 Moments of Transformation in Leadership
21:44 The Importance of Storytelling in Economics
22:51 Unlearning for Growth: Speed and Simplicity
28:02 Reprogramming Decision-Making Styles
29:03 The Future of Market Access in Healthcare
32:13 Emerging Trends in Healthcare Financing
35:53 Legacy and Leadership in Healthcare
39:15 Creating a Safe Environment for Team Dynamics
42:57 The Unique Superpower of Market Access Professionals
45:10 Understanding Introversion in Leadership
50:12 The Importance of Trusting Your Instincts
If you'd like to sponsor the show and elevate your brand with our audience, reach out to show host Kaushik Trivedi on LinkedIn and his team will reach out to fix up a chat to explore.
Connect with Kaushik Trivedi:
Instagram: https://www.instagram.com/drugdiaries_/
Linkedin: https://www.linkedin.com/in/kaushiktrivedi/
-
In this episode of Drug Diaries, Kaushik Trivedi and Isabelle Verniers delve into the complexities of talent development in the life sciences sector. They discuss the importance of nurturing talent beyond traditional qualifications, the invisible friction points that hinder development, and the balance between internal and external talent acquisition. The conversation also highlights practical tools for fostering talent and the competencies needed for future success in a rapidly evolving industry. In this conversation, Isabel and Kaushik delve into the importance of redefining soft skills as 'impact skills' that drive real change in organizations. They discuss the significance of structured talent development programs through case studies, emphasizing the need for a clear purpose, people engagement, and proficiency in fostering innovation. Isabel shares actionable steps for organizations to cultivate an innovation-ready culture, highlighting the value of starting small and learning from pilot programs. The discussion also touches on recommended readings that can enhance personal and professional growth, reinforcing the idea that transformation begins with individuals.
Talent is a combination of knowledge, skills, and attitude. Organizations have a responsibility to develop and nurture talent. Talent can be shaped and grown through the right environment. Purpose, people, and proficiency are essential for effective talent development. External hires are often seen as more innovative due to biases. Tools and templates facilitate consistent learning and development. Curiosity and adaptability are crucial for future competencies. Collaboration across functions is vital in life sciences. Engagement and motivation are key to successful talent development programs. Human skills, or 'impact skills', are increasingly important. The term 'soft skills' can undermine their importance; they should be called 'impact skills'. Impact skills are essential for mobilizing teams and driving results. Structured talent development programs can lead to significant organizational transformation. Consistency in talent development initiatives is crucial for long-term success. Cultural change requires clear purpose, engagement, and competency alignment. Starting small with pilot programs can effectively initiate change in legacy organizations. Reflection and self-assessment are key to understanding organizational readiness for innovation. Sharing successes within teams fosters motivation and a culture of learning. Books like 'Surrounded by Idiots' and 'Atomic Habits' provide valuable insights for personal growth. Organizations thrive when they invest in their people and create supportive environments.
Sound bites
"You can shape and nurture talent."
"Talent isn't a rare gift reserved for a few."
"Purpose, people, and proficiency are key."
"Engagement is key to talent development."
"Curiosity is crucial for talent development."
"Collaboration is vital in life sciences."
"Human skills are more important than ever."
"I don't like the term soft skills."
"You need to make clear choices."
"Start small, feel."
"It's all about getting stuff done."
"Look in the mirror."
Chapters
00:00 Understanding Talent in Life Sciences
09:18 Invisible Friction Points in Talent Development
14:30 Internal vs. External Talent Acquisition
18:02 Practical Tools for Talent Development
29:27 Future Competencies for Life Sciences
32:46 Rethinking Soft Skills: The Impact Skills Perspective
36:04 Case Studies in Talent Development: Success and Lessons Learned
42:08 Resetting Culture: The Three P's Approach
45:33 Starting Small: Piloting Change in Legacy Organizations
50:14 Actionable Steps for Innovation-Ready Culture
53:00 Recommended Reads: Books for Personal and Professional Growth
If you'd like to sponsor the show and elevate your brand with our audience, reach out to show host Kaushik Trivedi on LinkedIn and his team will reach out to fix up a chat to explore.
Connect with Kaushik Trivedi:
Instagram: https://www.instagram.com/drugdiaries_/
Linkedin: https://www.linkedin.com/in/kaushiktrivedi/
-
In this conversation, Chema and Kaushik explore the evolving landscape of the pharmaceutical industry, emphasizing the importance of patient-centric approaches and the integration of technology in enhancing patient experiences. They discuss the challenges faced by the industry, the need for empathy, and the significance of understanding patient behavior. Personal anecdotes highlight the impact of their work, showcasing the human side of healthcare and the potential of digital therapeutics to transform patient engagement.
Takeaways -
The pharmaceutical industry is undergoing significant changes, requiring a shift towards patient-centric approaches.
Empathy is crucial in understanding and addressing patient needs in healthcare.
Technology plays a vital role in enhancing patient experiences and engagement.
Personal stories can illustrate the real impact of pharmaceutical work on patients' lives.
Understanding patient behavior is essential for effective communication and engagement strategies.
Digital therapeutics (DTx) have the potential to revolutionize patient care and information access.
The industry must move beyond traditional metrics to measure success in patient engagement.
Collaboration with health patients is necessary for meaningful change in the industry.
There is a need to break down assumptions about patient behavior based on demographics.
The future of healthcare lies in understanding and responding to individual patient needs.
If you'd like to sponsor the show and elevate your brand with our audience, reach out to show host Kaushik Trivedi on LinkedIn and his team will reach out to fix up a chat to explore.
Connect with José Ma. (Chema) Guido Avila:
LinkedIn: https://www.linkedin.com/in/josemariaguido/
Connect with Kaushik Trivedi:
Instagram: https://www.instagram.com/drugdiaries_/
Linkedin: https://www.linkedin.com/in/kaushiktrivedi/
-
The video explores how artificial intelligence is transforming healthcare, with AI handling routine tasks to let humans focus on more critical work. This shift highlights the powerful synergy between technology and human expertise, driving significant healthcare innovation. Over 65% of pharma leaders report AI influencing real-time decisions, showcasing its impact on patient outcomes. The future of AI in healthcare emphasizes coordinated teamwork for better patient care. Chapters 00:00 – The Future of AI + Human Healthcare 01:18 – What Will AI Really Change? Hype vs Reality 02:08 – Welcome to Drug Daddies 02:29 – A Heartfelt Message: 93% Haven’t Subscribed 03:15 – Healthcare’s Silent AI Revolution 04:18 – AI Has Already Changed Healthcare 04:52 – Guest Introduction: Mohammed Haq, Cognizant 05:39 – Mohammed’s Journey + 30 Years of Experience 06:32 – The Perception Gap: People Think AI Is Future, Not Present 07:04 – The Biggest Misunderstanding About AI 08:49 – Fear of AI Replacing Jobs vs Reality of Augmentation 09:36 – Why AI Doesn’t Replace Clinicians 10:03 – The Power of Human + AI Teamwork 10:32 – The Moment AI Proved Itself: AlphaFold Breakthrough 11:28 – What’s Actually Real Today vs Still Hype 12:48 – The 6-Step Framework to Separate Signal from Noise 13:36 – Outcomes Matter: How to Evaluate AI Claims 15:15 – Winners Ask: Does AI Make Us Faster, Smarter, More Human? 15:40 – Where AI Is Saving Time, Money, and Lives 16:09 – Cognizant’s 3-Vector AI Strategy Explained 17:51 – Where AI Delivers the Most Value Across Pharma 18:17 – Using All 3 Vectors: What Clients Are Doing Today 19:29 – Agentic AI: How Mature Are These Technologies? 20:24 – Partnerships with NVIDIA, Microsoft, Google 21:53 – Why Ecosystems Win: AI at Global Scale 22:20 – What Patients Really Think About AI 23:46 – From Output to Action: The Rise of AI Agents 24:17 – Next 24 Months: Where AI Will Reshape Pharma 25:56 – The Real Barriers: Not Technology, Mindset 26:43 – BlueBolt: 53,000 People Building 30,000 AI Prototypes 28:09 – Culture Shift: Curiosity, Safety, and Innovation 28:37 – Which AI Use Cases Are Boardroom-Ready 29:30 – Clients Now Want Outcomes, Not Pilots 31:18 – The Market Is Changing Faster Than Ever 31:40 – Culture Eats Tech for Breakfast 32:38 – Democratizing Innovation at Cognizant 33:02 – How Leaders Build Safe + Ambitious AI Teams 33:37 – Predicting the Biggest Breakthrough in 2 Years 34:54 – The Excitement and Risks of AI in Healthcare 36:09 – AI: The New Electricity of Business 37:02 – Final Reflections: AI Completes Human Empathy 37:27 – Inspiring Close: AI Will Amplify the Human Heartbeat
-
The discussion highlights how "most favored nation" policies have evolved from theoretical policy discussions into tangible business challenges. This shift significantly impacts the "pharmaceutical industry", particularly concerning global strategies and "regulatory compliance". The conversation also delves into the implications of these policies, including the introduction of "tariffs", on international business practices. Chapters 00:00 – The Moment MFN Became Real A senior pharma leader’s launch dilemma turns MFN from theory into a business-critical threat. 02:50 – What Is MFN, Really? (Explained Simply) Chris breaks down MFN in plain language—and why it is not global price harmonisation. 05:00 – Explaining MFN to a 12-Year-Old Simple analogies that cut through the policy complexity. 07:30 – What Problem Is MFN Trying to Solve? Is MFN about affordability, fairness, leverage—or something else entirely? 10:00 – Will MFN Actually Lower Patient Out-of-Pocket Costs? Separating political rhetoric from real patient impact. 12:15 – MFN vs Recent ‘MFN-Like’ Pharma Deals Why recent Pfizer, AstraZeneca, and EMD agreements are not true MFN—and why that matters. 15:15 – Does MFN Reduce Prices or Just Shift Who Pays? Who really benefits: patients, governments, or budgets? 18:15 – “Europe Becomes a Risk, Not a Launch Anchor” Why global launch sequencing is being fundamentally rethought. 20:30 – The Global Ripple Effect: Who Feels MFN First? Which countries are most exposed—and why affordability has limits. 23:45 – MFN and R&D: What Innovation Gets Funded Next? How MFN could quietly reshape drug development priorities. 27:00 – Launch Sequencing, Evidence Strategy & Uncertainty Why companies must plan multiple launch paths simultaneously. 29:30 – Will MFN Spill Into Commercial Pricing? How Medicare and Medicaid policies may reshape the entire US market. 32:00 – Value-Based Pricing in an MFN World Why MFN complicates outcomes-based and value-based contracts. 34:30 – Confidential Discounts Under Threat Could MFN break the global confidential contracting model? 37:15 – Why Value Means Different Things in Different Countries How HTA frameworks, PICO, and comparators collide under price referencing. 40:00 – Could the World Move Toward Standardised Drug Pricing? The iPhone analogy—and why drugs are different. 42:40 – Extreme but Plausible MFN Scenarios (US Perspective) What “MFN-light” vs “MFN-heavy” futures could look like. 45:00 – Extreme but Plausible MFN Scenarios (Global Perspective) Where affordability breaks—and access risks emerge. 47:30 – The One Thing CEOs Should Do Now Scenario planning, signposts, and future-proofing launch strategy. 50:30 – Final Takeaways: MFN Is Not a Policy to Watch—It’s a Shift to Prepare For Why waiting is the biggest risk of all.
-
In this conversation Marek Rombel explains the importance of translating complex strategies into actionable steps for execution, emphasizing the role of cross-functional teams in ensuring clarity and effectiveness in product launches. takeaways A third of products launched are unsuccessful. Translating data and strategy is crucial for execution. Complex strategies can confuse customers if not simplified. Cross-functional teams are essential for distilling strategy. Effective execution requires clarity and simplicity. Being a great strategist also means being a great executionalist. Execution involves taking complex ideas and making them accessible. Customer confusion can stem from overly complex strategies. Successful product launches depend on clear communication. Collaboration across teams enhances execution effectiveness. Chapters 00:00 The Hidden Side of Success in Life Sciences 06:27 Lessons from a Seasoned Strategist 13:00 The Importance of Cross-Functional Collaboration 18:54 Market Conditioning and Messaging Strategies 23:29 Navigating Challenges in a Complex Landscape 27:55 Advice for Biotech Founders on Commercialization 33:52 Navigating Launch Challenges 38:19 The Importance of Empathy in Strategy 45:45 Building Collaborative Partnerships
-
In this conversation, Jill Donahue discusses the importance of influence and engagement in everyday interactions, emphasizing that serving others is key to finding purpose and achieving effective communication.
-
In this enlightening conversation, Dr. Ivan Diaz-Padilla shares his journey from clinician to global oncology leader, discussing the unpredictable nature of cancer research, the emotional resilience required in oncology, and the complexities of drug discovery. He emphasizes the importance of biomarkers, the challenges of immuno-oncology, and the need for patient-centric clinical trials. The discussion also touches on the global disparities in cancer treatment access and the hopeful advancements in cancer care that may redefine the future of oncology. Chapters 00:00 The Unexpected Truths of Cancer Research 02:11 The Journey from Bedside to Boardroom 03:45 Inflection Points in a Medical Career 05:39 The Transition from Clinician to Industry 08:08 Emotional Resilience in Oncology 09:50 Understanding the Drug Development Process 12:59 The Evolution of Immuno-Oncology 17:46 The Complexity of Combination Therapies 22:24 The Role of Biomarkers in Personalized Medicine 26:10 Balancing Ethics and Rigor in Clinical Trials 30:37 Patient-Centric Approaches in Clinical Trials 35:25 Learning from Clinical Trial Failures 38:23 Transformational Insights from Setbacks 41:58 The Role of AI in Oncology 46:29 Closing the Global Gap in Cancer Access 48:54 Optimism for the Future of Cancer Care 53:02 Legacy and Contributions to Oncology
- Visa fler
